Life ScienceCompany
Nevakar Injectables - Six Development-Stage Product Ownership
Who owns Nevakar Injectables - Six Development-Stage Product?
Nevakar Injectables - Six Development-Stage Product is owned by Endo International. It was acquired on May 2, 2022.
Nevakar Injectables - Six Development-Stage Product Business Overview
Where is Nevakar Injectables - Six Development-Stage Product headquartered?
Nevakar Injectables - Six Development-Stage Product is headquartered in Bridgewater, New Jersey.
What sector is Nevakar Injectables - Six Development-Stage Product in?
Nevakar Injectables - Six Development-Stage Product is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.